{"nctId":"NCT01861522","briefTitle":"The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis","startDateStruct":{"date":"2013-04"},"conditions":["Perennial Allergic Rhinitis"],"count":473,"armGroups":[{"label":"TAU-284","type":"EXPERIMENTAL","interventionNames":["Drug: Bepotastine besilate"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Bepotastine besilate","otherNames":["TALION 5mg tablets"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients aged between 7 and 15 years\n* Patients who have received a diagnosis of perennial allergic rhinitis according to the diagnostic criteria\n* Patients with a mean rhinorrhea score and a mean sneezing score of at least 2 on the basis of symptoms recorded in the nasal allergy diary during the observation period etc.\n\nExclusion Criteria:\n\n* Patients with vasomotor rhinitis or eosinophilic rhinitis\n* Patients who have concurrent nasal disease that may affect the efficacy of TAU-284\n* Patients with a history of any of the nasal surgical procedures\n* Patients who have a positive result for pollen antigens which are dispersed during the study period\n* Patients who have a positive result for dog dander or cat dander antigen and have a chance to touch dogs or cats.\n* Patients with current or previous history of drug allergy\n* Patients who concurrently have renal function abnormalities that may cause safety problems etc.","healthyVolunteers":false,"sex":"ALL","minimumAge":"7 Years","maximumAge":"15 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Total Score for the Three Major Nasal Symptoms [Sneezing, Rhinorrhea, and Nasal Congestion]","description":"Total score for the three major nasal symptoms (sneezing, rhinorrhea, and nasal congestion) were rated on 5-point scale ranging from 0 (no symptoms) to 4 (very severe).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.579","spread":"0.090"},{"groupId":"OG001","value":"-1.110","spread":"0.092"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Total Score for the Three Major Nasal Symptoms [Sneezing, Rhinorrhea, and Nasal Congestion]","description":null,"classes":[]},{"type":"SECONDARY","title":"Change From Baseline in Individual Nasal Symptom Scores (Sneezing, Rhinorrhea, Nasal Congestion, and Impairment in Daily Activities)","description":null,"classes":[]},{"type":"SECONDARY","title":"Change From Baseline in Individual Scores for Local Nasal Findings (Rhinoscopic Findings)","description":null,"classes":[]},{"type":"SECONDARY","title":"Change From Baseline in Severity Score for Symptoms of Allergic Rhinitis","description":null,"classes":[]},{"type":"SECONDARY","title":"Adverse Events and Adverse Drug Reactions","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":240},"commonTop":["Pharyngitis","Nasopharyngitis"]}}}